Taking NAMENDA

Important message regarding NAMENDA® (memantine HCl). Forest plans to discontinue the general sale and distribution of NAMENDA 5 mg and 10 mg tablets, beginning in January 2015. This is not due to any safety or efficacy issue related to NAMENDA tablets. More information will be available in the coming weeks about the plans to make Namenda tablets available through specialty pharmacy home delivery for patients whose physician indicates medical need.

The oral solution of NAMENDA will continue to be available, along with NAMENDA XR® (memantine HCl) extended‑release capsules.

Dosing and side effects information

How will my loved one take NAMENDA?

If you think NAMENDA (memantine HCl) may be right for your loved one, talk to your doctor about how to begin therapy.

Taking NAMENDA:

  • NAMENDA is recommended to be taken twice daily
  • NAMENDA can be taken with or without food
  • NAMENDA is available in in tablet and liquid form

Therapy begins at a low dose (5 mg per day) of NAMENDA and is gradually increased until the recommended target dose (10 mg, twice daily) is reached. A recommended dosing schedule for beginning NAMENDA therapy is provided below.

Recommended NAMENDA dosing schedule:

  • Week 1: Starting on Day 1. Take one 5 mg tablet in the morning, each day.
  • Week 2: Starting on Day 8. Take one 5 mg tablet in the morning and one 5 mg tablet at night, each day.
  • Week 3: Starting on Day 15. Take one 10 mg tablet in the morning and one 5 mg tablet at night, each day.
  • Week 4: Starting on Day 22. Take one 10 mg tablet in the morning and one 10 mg tablet at night, each day.

A dosing pack guides patients through the first four weeks of therapy, while dosage is gradually increased.

Once the recommended target dose of NAMENDA (10 mg, twice daily) has been reached, people taking NAMENDA can continue with that daily regimen unless instructed otherwise by their doctors. (For patients with severe renal impairment, 5 mg twice daily is the recommended dose.) As with all types of prescription medications, do not stop taking NAMENDA without first talking to a doctor.

NAMENDA® (memantine hydrochloride) is indicated for the treatment of moderate to severe dementia of the Alzheimer's type. NAMENDA is available by prescription only.

There is no evidence that NAMENDA prevents or slows the underlying disease process in patients with Alzheimer's disease.

IMPORTANT RISK INFORMATION FOR NAMENDA

Who should NOT take NAMENDA?
NAMENDA should not be taken by anyone who is allergic (hypersensitive) to memantine, the active substance in NAMENDA, or who has had a bad reaction to NAMENDA or any of its ingredients.

What should be discussed with the healthcare provider before taking NAMENDA?
Before starting NAMENDA, talk to the healthcare provider about all of the patient's past and present medical conditions, including:

  • Seizure disorders
  • Difficulty passing urine
  • Liver, kidney or bladder problems

If the patient is taking other medications (including those without a prescription), ask the healthcare provider if NAMENDA is right for the patient.

  • Certain medications, changes in diet, or medical conditions may affect the amount of NAMENDA in the body and possibly increase side effects.

What are the possible side effects of NAMENDA?
The most common side effects associated with NAMENDA treatment are dizziness, confusion, headache, and constipation. This is not a complete list of side effects.

Please see full Prescribing Information.

For Healthcare Professionals

The information in this website is intended for healthcare professionals in the United States.

I certify that I am a Healthcare Professional in the United States.

NO
YES
Email this Page
Complete the form below

Complete the form below to share the NAMENDA website with someone. A link to this page will be included in your message.

All fields are required

Please enter a name

Please enter an email address

Please enter a name

Please enter an email address

Emails do not match

Thank you for visiting

You are now leaving the NAMENDA Web site. Links to other Web sites are provided as a service to you. Forest Laboratories accepts no responsibility for the content of other Web sites. Would you like to continue?

CONTINUE
GO BACK